{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:11:56Z","timestamp":1792620716103,"version":"4.5.0"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,6,10]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Uncertainty remains about the efficacy of intravenous iron in patients with heart failure and iron deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the efficacy and safety of ferric carboxymaltose in patients with heart failure and iron deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter, randomized clinical trial enrolled 1105 patients with heart failure (defined as having a left ventricular ejection fraction of \u226445%) and iron deficiency (serum ferritin level &amp;amp;lt;100 ng\/mL; or if transferrin saturation was &amp;amp;lt;20%, a serum ferritin level between 100 ng\/mL and 299 ng\/mL) at 70 clinic sites in 6 European countries from March 2017 to November 2023. The median follow-up was 16.6 months (IQR, 7.9-29.9 months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Administration of ferric carboxymaltose (n\u2009=\u2009558) initially given at an intravenous dose of up to 2000 mg that was followed by 500 mg every 4 months (unless stopping criteria were met) vs a saline placebo (n\u2009=\u2009547).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      The primary end point events were (1) time to cardiovascular death or first heart failure hospitalization, (2) total heart failure hospitalizations, and (3) time to cardiovascular death or first heart failure hospitalization in patients with a transferrin saturation less than 20%. All end point events were measured through follow-up. The end points would be considered statistically significant if they fulfilled at least 1 of the following conditions: (1)\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\u2264\u2009.05 for all 3 of the end point comparisons, (2)\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\u2264\u2009.025 for 2 of the end point comparisons, or (3)\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\u2264\u2009.0167 for any of the 3 end point comparisons (Hochberg procedure).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 1105 participants (mean age, 70 years [SD, 12 years]; 33% were women), cardiovascular death or first heart failure hospitalization (first primary outcome) occurred in 141 in the ferric carboxymaltose group vs 166 in the placebo group (hazard ratio, 0.79 [95% CI, 0.63-0.99];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04). The second primary outcome (total heart failure hospitalizations) occurred 264 times in the ferric carboxymaltose group vs 320 times in the placebo group (rate ratio, 0.80 [95% CI, 0.60-1.06];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.12). The third primary outcome (cardiovascular death or first heart failure hospitalization in patients with a transferrin saturation &amp;amp;lt;20%) occurred in 103 patients in the ferric carboxymaltose group vs 128 patients in the placebo group (hazard ratio, 0.79 [95% CI, 0.61-1.02],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.07). A similar amount of patients had at least 1 serious adverse event in the ferric carboxymaltose group (269; 48.2%) vs in the placebo group (273; 49.9%) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.61).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the overall cohort or in patients with a transferrin saturation less than 20%, or reduce the total number of heart failure hospitalizations vs placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT03036462?id=NCT03036462&amp;amp;amp;rank=1\">NCT03036462<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2025.3833","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:30:57Z","timestamp":1743327057000},"page":"1965","source":"Crossref","is-referenced-by-count":80,"title":["Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency"],"prefix":"10.1001","volume":"333","author":[{"given":"Stefan D.","family":"Anker","sequence":"first","affiliation":[{"name":"Deutsches Herzzentrum der Charit\u00e9, Campus Virchow Klinikum, Berlin, Germany"},{"name":"Institute of Health Centre for Regenerative Therapies, German Centre for Cardiovascular Research, partner site Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Friede","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Centre G\u00f6ttingen, G\u00f6ttingen, Germany"},{"name":"German Centre for Cardiovascular Research, partner site Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Mississippi Medical Center, Jackson"},{"name":"Baylor Scott and White Research Institute, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawaja M.","family":"Talha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Loyola University Medical Centre, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Placzek","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Centre G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Diek","sequence":"additional","affiliation":[{"name":"Deutsches Herzzentrum der Charit\u00e9, Campus Virchow Klinikum, Berlin, Germany"},{"name":"Institute of Health Centre for Regenerative Therapies, German Centre for Cardiovascular Research, partner site Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nosko","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane","family":"Stas","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Lower Saxony, Germany"},{"name":"Department of Medical Informatics, University Medical Centre G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Jarczak","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"deHeer","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Rybczynski","sequence":"additional","affiliation":[{"name":"University Heart and Vascular Centre Hamburg, Department of Cardiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany"},{"name":"German Centre for Cardiovascular Research, partner site Hamburg\/Kiel\/L\u00fcbeck, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Bay\u00e9s-Gen\u00eds","sequence":"additional","affiliation":[{"name":"Heart Institute, Hospital Universitari Germans Trias i Pujol, CIBERCV, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Department of Medicine III and Homburg Institute for Cardio, Renal, and Metabolic Medicine, Saarland University, Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J. S.","family":"Coats","sequence":"additional","affiliation":[{"name":"Heart Research Institute, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Edelmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9, Campus Virchow Klinikum, Berlin, Germany"},{"name":"German Centre for Cardiovascular Research, partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Hasenfu\u00df","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Lower Saxony, Germany"},{"name":"Department of Cardiology and Pneumology, University Medical Centre G\u00f6ttingen, Georg August University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Haverkamp","sequence":"additional","affiliation":[{"name":"Deutsches Herzzentrum der Charit\u00e9, Campus Virchow Klinikum, Berlin, Germany"},{"name":"Institute of Health Centre for Regenerative Therapies, German Centre for Cardiovascular Research, partner site Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[{"name":"Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"},{"name":"Department of Cardiology, Angiology, and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9, Campus Benjamin Franklin, Berlin, Germany"},{"name":"Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain C.","family":"Macdougall","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, King\u2019s College Hospital, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Merkely","sequence":"additional","affiliation":[{"name":"Heart and Vascular Centre, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert M.","family":"Pieske","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University Medicine Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[{"name":"Centro Academico de Medicina de Lisboa, CCUL@RISE, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[{"name":"West German Heart and Vascular Centre, Department of Cardiology and Vascular Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Visser-Rogers","sequence":"additional","affiliation":[{"name":"Coronado Research, Newcastle, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Promotion of Quality of Life, San Raffaele Open University of Rome, Rome, Italy"},{"name":"Cardiology, San Raffaele Cassino Hospital, Cassino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Promotion of Quality of Life, San Raffaele Open University of Rome, Rome, Italy"},{"name":"IRCCS San Raffaele Roma, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Lower Saxony, Germany"},{"name":"Department of Cardiology and Pneumology, University Medical Centre G\u00f6ttingen, Georg August University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S.","family":"Anker","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"},{"name":"Department of Cardiology, Angiology, and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9, Campus Benjamin Franklin, Berlin, Germany"},{"name":"Berlin Institute of Health, Berlin, Germany"},{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health-Centre for Regenerative Therapies and Department of Cardiology, Deutsches Herzzentrum der Charit\u00e9 and German Centre for Cardiovascular Research, partner site Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Ince","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University Medicine Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Koehler","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"},{"name":"Department of Cardiology, Angiology, and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9, Campus Charit\u00e9 Mitte, Berlin, Germany"},{"name":"Centre for Cardiovascular Telemedicine, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Research Institute, Dallas, Texas"},{"name":"Baylor Scott and White Health, Heart Hospital, Plano, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Rauch-Kr\u00f6hnert","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"},{"name":"Department of Cardiology, Angiology, and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9, Campus Benjamin Franklin, Berlin, Germany"},{"name":"Berlin Institute of Health, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiology I, University Medical Centre Mainz, Mainz, Germany"},{"name":"German Centre for Cardiovascular Research, Standort RheinMain, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Trenkwalder","sequence":"additional","affiliation":[{"name":"Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Diseases, German Heart Centre Munich, TUM University Hospital, Munich, Germany"},{"name":"German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology, and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany"},{"name":"German Centre for Cardiovascular Research, partner site Heidelberg\/Mannheim, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Paitazoglou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, and Intensive Care Medicine, University Heart Centre L\u00fcbeck, Medical Clinic II, University Hospital Schleswig-Holstein, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Kobielusz-Gembala","sequence":"additional","affiliation":[{"name":"O\u015bwi\u0119cimskie Centrum Bada\u0144 Klinicznych, O\u015bwi\u0119cim, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Kuthi","sequence":"additional","affiliation":[{"name":"Heart and Vascular Centre, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, and Pneumolgy, Clinical Trial Unit, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Licka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, and Pneumolgy, Clinical Trial Unit, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00e4\u00e4b","sequence":"additional","affiliation":[{"name":"Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany"},{"name":"Department of Internal Medicine I, Technical University Munich University Hospital, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Medical University and University Hospital, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahir","family":"Karakas","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany"},{"name":"German Centre for Cardiovascular Research, partner site Hamburg\/Kiel\/L\u00fcbeck, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"joi250017r1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/CIRCRESAHA.122.321667","article-title":"Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets.","volume":"132","author":"Sawicki","year":"2023","journal-title":"Circ Res"},{"issue":"11","key":"joi250017r2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure.","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"joi250017r3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview.","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"15","key":"joi250017r4","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure.","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"issue":"25","key":"joi250017r5","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency.","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"joi250017r6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency.","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"issue":"10266","key":"joi250017r7","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"issue":"10369","key":"joi250017r8","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"joi250017r9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency.","volume":"389","author":"Mentz","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"joi250017r10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4081\/cardio.2023.17","article-title":"Defining iron replete status in patients with heart failure treated with intravenous iron.","volume":"1","author":"Talha","year":"2023","journal-title":"Global Cardiol"},{"issue":"2","key":"joi250017r11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients.","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"48","key":"joi250017r12","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"},{"key":"joi250017r13","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3574","article-title":"Rationale and design of the FAIR-HF2-DZHK05 trial: ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure.","author":"Anker","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"joi250017r14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/1467-9868.00259","article-title":"Semiparametric regression for the mean and rate functions of recurrent events.","volume":"62","author":"Lin","year":"2000","journal-title":"J R Stat Soc Ser B Stat Method"},{"issue":"4","key":"joi250017r15","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance.","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"issue":"2","key":"joi250017r16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4081\/cardio.2024.33","article-title":"Using multiple primary endpoints in clinical trials with a focus on heart failure.","volume":"2","author":"Anker","year":"2024","journal-title":"Global Cardiol"},{"issue":"9","key":"joi250017r17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"joi250017r18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.124.068883","article-title":"Redefining iron deficiency in patients with chronic heart failure.","volume":"150","author":"Packer","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"joi250017r19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"joi250017r20","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/ejhf.3237","article-title":"Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure.","volume":"26","author":"Packer","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"joi250017r21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ejhf.2860","article-title":"Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: a bayesian meta-analysis.","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"joi250017r22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC).","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"joi250017r23","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines.","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2832132\/jama_anker_2025_oi_250017_1748540686.90174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:00:44Z","timestamp":1749553244000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2832132"}},"subtitle":["The FAIR-HF2 DZHK05 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":23,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,6,10]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.3833","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}